AI Article Synopsis
- Some studies suggest that immunotherapy might make different areas of cancer act in unpredictable ways in the same person.
- Researchers created a model to understand these variations and how they affect patients' survival.
- They found that tracking these differences in cancer behavior is more helpful for predicting which patients are at higher risk than just measuring the biggest tumor size.
Article Abstract
Purpose: Several studies have raised the hypothesis that immunotherapy may exacerbate the variability in individual lesions, increasing the risk of observing divergent kinetic profiles within the same patient. This questions the use of the sum of the longest diameter to follow the response to immunotherapy. Here, we aimed to study this hypothesis by developing a model that estimates the different sources of variability in lesion kinetics, and we used this model to evaluate the impact of this variability on survival.
Methods: We relied on a semimechanistic model to follow the nonlinear kinetics of lesions and their impact on the risk of death, adjusted on organ location. The model incorporated two levels of random effects to characterize both between- and within-patient variability in response to treatment. The model was estimated on 900 patients from a phase III randomized trial evaluating programmed death-ligand 1 checkpoint inhibitor atezolizumab versus chemotherapy in patients with second-line metastatic urothelial carcinoma (IMvigor211).
Results: The within-patient variability in the four parameters that characterize individual lesion kinetics represented between 12% and 78% of the total variability during chemotherapy. Similar results were obtained during atezolizumab, except for the durability of the treatment effects, for which the within-patient variability was markedly larger than during chemotherapy (40% 12%, respectively). Accordingly, the occurrence of divergent profile consistently increased over time in patients treated with atezolizumab and was equal to about 20% after 1 year of treatment. Finally, we show that accounting for the within-patient variability provided a better prediction of most at-risk patients than a model relying solely on the sum of the longest diameter.
Conclusion: Within-patient variability provides valuable information for the assessment of treatment efficacy and the detection of at-risk patients.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1200/PO.22.00368 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Optimal timing for epinephrine administration in adult patients with out-of-hospital cardiac arrest: A retrospective observational study.
Acad Emerg Med
January 2025
Department of Emergency and Critical Care Medicine, Saitama Medical Center, Jichi Medical University, Saitama, Japan.
Background: This study aimed to clarify the appropriate timing for epinephrine administration in adults with out-of-hospital cardiac arrest (OHCA), particularly those cases with nonshockable rhythms, by addressing resuscitation time bias.
Methods: We performed a retrospective observational study utilizing a multicenter OHCA registry involving 95 hospitals in Japan between June 2014 and December 2020. We included patients with OHCA and nonshockable rhythms who received epinephrine during resuscitation.
Employing artificial intelligence for optimising antibiotic dosages in sepsis on intensive care unit: a study protocol for a prospective observational study (KI.SEP).
BMJ Open
December 2024
Klinik für Anästhesiologie, Intensivmedizin und Schmerztherapie, Universitätsklinikum Knappschaftskrankenhaus Bochum GmbH, Bochum, Germany
Introduction: In sepsis treatment, achieving and maintaining effective antibiotic therapy is crucial. However, optimal antibiotic dosing faces challenges due to significant variability among patients with sepsis. Therapeutic drug monitoring (TDM), the current gold standard, lacks initial dosage adjustments and global availability.
View Article and Find Full Text PDFVariation in adherence measures as a function of calculation methods.
Front Pharmacol
November 2024
University of Pittsburgh, School of Nursing, Pittsburgh, PA, United States.
Aim: We aim to compare different operational definitions of medication adherence as well as examine the within-patient variability among these measures among patients treated for multiple comorbid conditions.
Methods: Electronically monitored adherence data from a study on comorbid conditions were examined using three different calculation methods. DAILY adherence calculated the number of administrations divided by the number prescribed, without considering inter-dose interval.
Type 1 Immune Responses Related to Viral Infection Influence Corticosteroid Response in Asthma.
Am J Respir Crit Care Med
November 2024
National Jewish Health, Denver, Colorado, United States;
Rationale: Corticosteroid-responsive type 2 (T2) inflammation underlies the T2-high asthma endotype. However, we hypothesized that type 1 (T1) inflammation, possibly related to viral infection, may also influence corticosteroid response.
Objectives: To determine the frequency and within-patient variability of T1-high, T2-high, and T1/T2-high asthma endotypes and whether virally influenced T1-high disease influences corticosteroid response in asthma.
Identifiable Historic and Observable Factors May Predict Progression to Exfoliation Glaucoma in Newly Diagnosed Exfoliation Patients.
Ophthalmol Glaucoma
October 2024
Ophthalmology & Visual Sciences, University of Utah School of Medicine, Moran Eye Center, Salt Lake City, Utah.
Objective: To identify clinical factors associated with conversion to exfoliation glaucoma (XFG) in exfoliation syndrome (XFS) patients who are most at risk of progression to XFG within 3 years for increased surveillance and early preventive interventions.
Design: A retrospective patient cohort study design was employed.
Subjects: A source population of XFS patients ≥ 50 years was identified from electronic medical records in the Utah Population Database.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!